| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 A&G Pharmaceutical, Columbia, Maryland; 2 Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland; and 3 Program in Oncology, Greenebaum Cancer Center of the University of Maryland, Baltimore, Maryland
PC cell-derived growth factor, also known as progranulin, is an Mr 88,000 growth factor (referred as PCDGF/GP88) overexpressed in human breast cancer. Antisense inhibition of PCDGF/GP88 expression in MDA-MB-468 cells inhibited tumor formation in nude mice. In estrogen receptor-positive cells, PCDGF/GP88 was expressed in response to estradiol and shown to mediate its mitogenic effect. Pathologic studies indicated that PCDGF/GP88 was expressed in 80% of invasive ductal carcinomas in correlation with parameters of poor prognosis. In the present article, the relationship between PCDGF/GP88 expression and tamoxifen resistance was examined in MCF-7 cells. PCDGF/GP88 overexpression rendered MCF-7 cells able to proliferate in the absence of estrogen and in the presence of tamoxifen. The PCDGF/GP88-overexpressing cells formed tumors in ovariectomized nude mice in the absence of estradiol and in its presence, in contrast to MCF-7 cells. Tumor growth of the overexpressing cells was increased significantly when the mice were treated with tamoxifen. PCDGF/GP88 blocked tamoxifen-induced apoptosis by preventing down-regulation of bcl-2 expression and poly(ADP-ribose) polymerase cleavage. In addition, PCDGF/GP88-overexpressing cells presented higher level of the angiogenic factors vascular endothelial growth factor and angiopoietin-1 than MCF-7 control cells. Tamoxifen treatment additionally increased the level of vascular endothelial growth factor. These studies suggest that PCDGF/GP88 plays a critical role in breast cancer tumorigenesis and in the transition to estrogen independence and tamoxifen resistance, a hallmark of poor prognosis. On the basis of the in vivo studies, it is postulated that tamoxifen treatment of patients with estrogen receptor-positive breast tumors overexpressing PCDGF/GP88 could have adverse clinical consequences.
This article has been cited by other articles:
|
|
 |
|
  J. A Desmarais, M. Cao, A. Bateman, and B. D Murphy Spatiotemporal expression pattern of progranulin in embryo implantation and placenta formation suggests a role in cell proliferation, remodeling, and angiogenesis Reproduction, August 1, 2008; 136(2): 247 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Van Damme, A. Van Hoecke, D. Lambrechts, P. Vanacker, E. Bogaert, J. van Swieten, P. Carmeliet, L. Van Den Bosch, and W. Robberecht Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival J. Cell Biol., April 3, 2008; 181(1): 37 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tolkatchev, S. Malik, A. Vinogradova, P. Wang, Z. Chen, P. Xu, H. P.J. Bennett, A. Bateman, and F. Ni Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities Protein Sci., April 1, 2008; 17(4): 711 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S.N. Shim, I. A.W. Ho, and P. E.H. Wong Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis Mol. Cancer Res., July 1, 2007; 5(7): 655 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Lin, Y. Yu, H. Zhao, Y. Zhang, J. Manela, and D. A. Tonetti Overexpression of PKC{alpha} is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model Carcinogenesis, August 1, 2006; 27(8): 1538 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Kim and G. Serrero PC Cell-Derived Growth Factor Stimulates Proliferation and Confers Trastuzumab Resistance to Her-2-Overexpressing Breast Cancer Cells. Clin. Cancer Res., July 15, 2006; 12(14): 4192 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Jones, A. P. Houwink, B. K. Freeman, T. M. Greenwood, J. M. Lafky, W. L. Lingle, A. Berchuck, G. L. Maxwell, K. C. Podratz, and N. J. Maihle The Granulin-Epithelin Precursor Is a Steroid-Regulated Growth Factor in Endometrical Cancer Reproductive Sciences, May 1, 2006; 13(4): 304 - 311. [Abstract] [PDF]
|
|
|
|
|
|
W. Wang, J. Hayashi, and G. Serrero PC Cell-Derived Growth Factor Confers Resistance to Dexamethasone and Promotes Tumorigenesis in Human Multiple Myeloma Clin. Cancer Res., January 1, 2006; 12(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Gaben, C. Saucier, M. Bedin, G. Redeuilh, and J. Mester Mitogenic Activity of Estrogens in Human Breast Cancer Cells Does Not Rely on Direct Induction of Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase or Phosphatidylinositol 3-Kinase Mol. Endocrinol., November 1, 2004; 18(11): 2700 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Tangkeangsirisin and G. Serrero PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells Carcinogenesis, September 1, 2004; 25(9): 1587 - 1592. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
